Alemtuzumab as compared to alternative contemporary induction regimens.

LaMattina, John C

Alemtuzumab as compared to alternative contemporary induction regimens. [electronic resource] - Transplant international : official journal of the European Society for Organ Transplantation May 2012 - 518-26 p. digital

Publication Type: Comparative Study; Journal Article

1432-2277

10.1111/j.1432-2277.2012.01448.x doi


Adult
Alemtuzumab
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized--adverse effects
Antilymphocyte Serum--therapeutic use
Basiliximab
Female
Graft Rejection--etiology
Graft Survival
Humans
Immunosuppressive Agents--therapeutic use
Infections--etiology
Kaplan-Meier Estimate
Kidney Transplantation--adverse effects
Leukopenia--etiology
Male
Middle Aged
Recombinant Fusion Proteins--therapeutic use
Retrospective Studies
Risk Factors
Treatment Outcome